Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. dr. Fritz Offner

Work address: C. Heymanslaan 10
9000 Gent
Email: Fritz.Offner@UGent.be
ORCID iD: https://orcid.org/0000-0003-4690-3603

Show Sort by

Mark
- journalArticle
- A1
- open access
Central nervous system relapse in patients over 80 years with diffuse large B-cell lymphoma : an analysis of two LYSA studies

Aurélie Cabannes-Hamy, Frederic Peyrade, Fabrice Jardin, Jean-François Emile, Vincent Delwail, Nicolas Mounier, Corinne Haioun, Aurore Perrot, Olivier Fitoussi, Diane Lara, et al.

(2018) CANCER MEDICINE. 7(3). p.539-548
Mark
A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma : a retrospective training and validation analysis in three international cohorts

Sarah Huet, Bruno Tesson, Jean-Philippe Jais, Andrew L Feldman, Laura Magnano, Emilie Thomas, Alexandra Traverse-Glehen, Benoit Albaud, Marjorie Carrere, Luc Xerri, et al.

(2018) LANCET ONCOLOGY. 19(4). p.549-561
Mark
- journalArticle
- A1
- open access
Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies

Dorien Clarisse (UGent) , Karlien Van Wesemael (UGent) , Jan Tavernier (UGent) , Fritz Offner (UGent) , Ilse Beck (UGent) and Karolien De Bosscher (UGent)

(2018) PLOS ONE. 13(5).
Mark
- conference
- C3
Phase 1b/3 study of avelumab-based combination regimens in patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL)

Robert W Chen, Stephen Maxted Ansel, Pier Luigi Zinzani, Jeffrey L Vacirca, Armando Lopez-Guillermo, Martin Hutchings, Wojciech Jurczak, Georg Hess, Steven Le Gouill, Fritz Offner (UGent) , et al.

(2017) JOURNAL OF CLINICAL ONCOLOGY. 35(suppl. 15).
Mark
- conference
- C3
The impact of the updated IMWG diagnostic criteria in a real-life SMM cohort : a single center experience

Philip Vlummens (UGent) and Fritz Offner (UGent)

(2017) HAEMATOLOGICA. 102(suppl. 2). p.779-779
Mark
Phase I dose-escalation study of the anti-CD70 antibody ARGX-110 in advanced malignancies

Philippe Aftimos, Christian Rolfo, Sylvie Rottey (UGent) , Fritz Offner (UGent) , Dominique Bron, Marie Maerevoet, Jean-Charles Soria, Mahan Moshir, Torsten Dreier, Luc Van Rompaey, et al.

(2017) CLINICAL CANCER RESEARCH. 23(21). p.6411-6420
Mark
- journalArticle
- A1
- open access
Coregulator profiling of the glucocorticoid receptor in lymphoid malignancies

Dorien Clarisse (UGent) , Jonathan Thommis (UGent) , Karlien Van Wesemael (UGent) , Rene Houtman, Dariusz Ratman (UGent) , Jan Tavernier (UGent) , Fritz Offner (UGent) , Ilse Beck (UGent) and Karolien De Bosscher (UGent)

(2017) ONCOTARGET. 8(65). p.109675-109691
Mark
- journalArticle
- A1
- open access
Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia : results of a phase II study

Vincent Ribrag, Won Seog Kim, Reda Bouabdallah, Soon Thye Lim, Bertrand Coiffier, Arpad Illes, Bernard Lemieux, Martin JS Dyer, Fritz Offner (UGent) , Zakia Felloussi, et al.

(2017) HAEMATOLOGICA. 102(5). p.903-909
Mark
- conference
- C3
Clinical response observed in a phase I study in T cell lymphoma patients treated with anti-CD70 SIMPLE antibody ARGX-110

Jean-Marie Michot, Marie Maerevoet, Philippe Georges Aftimos, Sylvie Rottey (UGent) , Christian Diego Rolfo, Fritz Offner (UGent) , Luc Van Rompaey, Mahan Moshir, Hans de Haard, Karen Silence, et al.

(2016) JOURNAL OF CLINICAL ONCOLOGY. 34(15, suppl.).
Mark
- conference
- C3
The mineralocorticoid receptor is involved in glucocorticoid resistance

Dorien Clarisse (UGent) , Fritz Offner (UGent) , Karolien De Bosscher (UGent) and Ilse Beck (UGent)

(2016) Nuclear Receptor Research Network, 9th Meeting, Abstracts.

1
2
3
4
…
22
23

Next →